Literature DB >> 2164560

Detection of integrated hepatitis B virus DNA in hepatocellular carcinoma cell lines by nonradioactive in situ hybridization.

N Tay1, S H Chan, E C Ren.   

Abstract

A sensitive and specific nonradioactive in situ hybridization method capable of detecting single-copy integrated hepatitis B virus (HBV) DNA sequences in hepatocellular carcinoma (HCC) cell lines was developed. In situ hybridization of biotinylated HBV (adr, adw) DNA probes with nine different human HCC cell lines were carried out in 96-well microtiter plates. Integration was detected in HCC cell lines HCCM, Hep3B, huH-1, huH-4, and PLC/PRF/5. Detection of single-copy HBV DNA sequences was also achieved in Hep3B and huH-4. HCC cell lines HepG2, HUH-6, HUH-7, Mahlavu, and the non-HCC control MCF-7, gave clear negative results. These results show a 100% correlation with those obtained by Southern blot hybridization assay. The results demonstrate that nonradioactive detection of single-copy integrated HBV DNA sequences in HCC cell lines is possible by the method described, which has potential application for viral genome analysis requiring in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164560     DOI: 10.1002/jmv.1890300407

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Significance of HBV DNA in the hepatic parenchyma from patients with non-B, non-C hepatocellular carcinoma.

Authors:  Takuya Nakai; Osamu Shiraishi; Takashi Kawabe; Hideo Ota; Hiroaki Nagano; Hitoshi Shiozaki
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).

Authors:  Wenhui Wang; Yan Chen; Liang Wu; Yi Zhang; Seungyeul Yoo; Quan Chen; Shiping Liu; Yong Hou; Xiao-Ping Chen; Qian Chen; Jun Zhu
Journal:  BMC Med Genomics       Date:  2022-06-16       Impact factor: 3.622

3.  Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.

Authors:  Cord C Uphoff; Sabine A Denkmann; Klaus G Steube; Hans G Drexler
Journal:  J Biomed Biotechnol       Date:  2010-04-29

4.  Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II.

Authors:  N Tay; S H Chan; E C Ren
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.

Authors:  Mothanna Al-Qubaisi; Rosli Rozita; Swee-Keong Yeap; Abdul-Rahman Omar; Abdul-Manaf Ali; Noorjahan B Alitheen
Journal:  Molecules       Date:  2011-04-06       Impact factor: 4.411

6.  Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.

Authors:  Lan-Ting Yuan; Wei-Jiunn Lee; Yi-Chieh Yang; Bo-Rong Chen; Ching-Yao Yang; Min-Wei Chen; Ji-Qing Chen; Michael Hsiao; Ming-Hsien Chien; Kuo-Tai Hua
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 7.  Cellular Genomic Sites of Hepatitis B Virus DNA Integration.

Authors:  Magdalena A Budzinska; Nicholas A Shackel; Stephan Urban; Thomas Tu
Journal:  Genes (Basel)       Date:  2018-07-20       Impact factor: 4.096

8.  Accurate targeted long-read DNA methylation and hydroxymethylation sequencing with TAPS.

Authors:  Yibin Liu; Jingfei Cheng; Paulina Siejka-Zielińska; Carika Weldon; Hannah Roberts; Maria Lopopolo; Andrea Magri; Valentina D'Arienzo; James M Harris; Jane A McKeating; Chun-Xiao Song
Journal:  Genome Biol       Date:  2020-03-03       Impact factor: 13.583

9.  Identification of Characteristic Genomic Markers in Human Hepatoma HuH-7 and Huh7.5.1-8 Cell Lines.

Authors:  Masaki Kawamoto; Toshiyuki Yamaji; Kyoko Saito; Yoshitaka Shirasago; Kazuhiro Satomura; Toshinori Endo; Masayoshi Fukasawa; Kentaro Hanada; Naoki Osada
Journal:  Front Genet       Date:  2020-10-09       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.